FindMyKOL

Ala Mohsen, MD

Basic profile

East Jefferson General Hospital

ORCIDNone on fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionMetairie, LA · South CentralSpecialtyInterventional CardiologyFocusCardiology
Active KOLFindMyKOL type: RegionalLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Ala Mohsen is a Cardiology physician affiliated with East Jefferson General Hospital. OpenAlex indexes 21 publications with 375 citations (h-index 7).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
21publications

Publications indexed by OpenAlex. Counts exclude supporting files.

375citations

Citations across these publications.

7h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
35companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

35 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Stryker Corporation
    Program year20257 payments
    $352
  • Shockwave Medical, Inc
    Program year20253 payments
    $340
  • Inari Medical, Inc.
    Program year20251 payment
    $176
All 71 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    79.7%
    Beta blocker19.6%
    Metoprolol Succinate67%Metoprolol Tartrate14%Carvedilol8%Sotalol7%Atenolol2%Nebivolol Hcl2%
    Part D<11 patients
    Statin17.1%
    Atorvastatin Calcium66%Rosuvastatin Calcium19%Pravastatin Sodium12%Simvastatin3%
    Part D<11 patients

    + 12 more classes in this area

  • Blood & clotting

    18.4%
    Factor Xa inhibitor13%
    Eliquis89%Xarelto11%
    Part D≥107 patients
    P2Y12 inhibitor4.2%
    Clopidogrel86%Brilinta14%
    Part D<11 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    1.9%
    Potassium supplement1.9%
    Potassium Chloride100%
    Part D≥25 patients
Where care is delivered (Part B)73.7% facility · 26.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”